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oi.or1We studied whether allospecific CD4 effector memory T cells (TEM) could induce graft-versus-host disease
(GVHD) using a novel GVHD model induced solely by CD41 T cell receptor transgenic TEa cells. Allospe-
cific TEM generated in a lymphopenic host bore a typical memory phenotype. Moreover, these cells were able
to elicit a faster and more effective proliferative response on challenge with alloantigen in vitro and to me-
diate ‘‘second-set’’ skin graft rejection in vivo. However, these allospecific TEM were unable to induce GVHD.
Allospecific TEM recipients became tolerant to alloantigen as a result of clonal deletion. Even though allospe-
cific TEM were able to respond to alloantigen initially, the expansion of these cells and inflammatory cytokine
production during GVHD were dramatically decreased. The inability of allospecific TEM to sustain the
alloresponse may be a result of enhanced activation-induced cell death. These observations provide insight
into how allospecific CD41 TEM respond to alloantigen during GVHD and underscore the fundamental
differences in alloresponses mediated by allospecific TEM in graft rejection and GVHD settings.
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T cell memoryINTRODUCTION
Memory immune response is specific to the antigen
that has been encountered previously and is mediated
by memory lymphocytes [1]. In organ transplantation,
memory response is also called ‘‘second set’’ rejection
[2,3]. Non-allospecific memory T cells that cross-
react with alloantigens have been detected in unprimed
recipients [4]. Based on observations in organ trans-
plantation [4], it has been presumed that memory
T cells from both primed and unprimed donors would
induce more severe graft-versus-host disease (GVHD)
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demonstrating that effector memory T cells (TEM)
from non–alloantigen-sensitized donors do not
induce GVHD in different animal models [5-9].
These published data indicate that TEM isolated
from unprimed donors and containing mostly
nonalloreactive T cells, and likely some cross-reactive
T cells as well, are unable to induce GVHD.
Because this approach has the potential to transfer
memory T cell immunity against infectious agents and
tumors to the host without inducing GVHD, there is
great enthusiasm for translating these findings into
the clinical setting. One of the major concerns is the
existence of cross-reactive and even true allospecific
memory T cells in humans [4,10]. Humans do not
live in a specific pathogen-free environment and likely
contain more cross-reactive T cells than mice do
[4,10]. In parous females or donors who have had
undergone previous transfusion or transplantation,
memory T cells may contain true allospecific T cells
[10]. Allospecificmemory T cells also can be generated
as a result of homeostatic proliferation of allospecific
na€ıve T cells [11]. Because both cross-reactive and al-
lospecific memory T cells have been shown to mediate
quicker and more effective immune responses in organ
transplantation settings [10], determining how allo-
specific memory T cells respond in the GVHD setting
is of critical importance.
Dutt et al. [12] demonstrated that TEM from
alloantigen-primed donors induced a chronic form of
Biol Blood Marrow Transplant 18:1488-1499, 2012 1489Allospecific TEM Do Not Induce GVHDGVHD, in contrast to the acute GVHD induced by
na€ıve T cells. A recent report also suggested that the
alloprimed TEM induce only mild GVHD [13]. In
these models, a heterogeneous population of memory
T cells, in which allospecific memory T cells represent
only a small portion of total cells, were used. To exam-
ine the role of allospecific TEM in GVHD in more de-
tail, we established a GVHD model induced solely by
TEa CD41 T cell receptor transgeneic T cells. TEa
cells are TCR-transgenic CD41 T cells with a single
defined specificity against IEa52-68 peptide in the
context of I-Ab [14]. Using this model, we demon-
strated that allospecific TEM were unable to induce
GVHD. The fact that all TEa cells have single antigen
specificity and can be tracked in vivo allowed us to
study the mechanisms by which allospecific TEM
were unable to induce GVHD.MATERIALS AND METHODS
Mice
C57BL/6 (H2b,CD229.12),B6.129S7-Rag1tm1Mom/
J (Rag-12/2, H2b, CD229.12), and CB6F1 (H2b/d,
CD229.11) mice were purchased from Jackson Labo-
ratories (Bar Harbor, ME). TEa transgenic breeders
(C57BL/6 background, CD229.12; a generous gift
fromDr. Alexander Rudensky, University ofWashing-
ton), which express a TCR that recognizes a peptide
expressed in all antigen-presenting cells from H2b/
I-E1 strains, such as CB6F1 [14], were bred at Duke
University. Primarily female mice were used in this
study. Most of the unprimed donor mice were between
6 and 10 weeks of age at the beginning of the study.
Recipient mice were 7-12 weeks old at the time of
transplantation. All mice were housed in a specific
pathogen-free facility throughout the study period.T Cell Depletion from Bone Marrow
T cells were depleted from bone marrow (BM) us-
ing anti-Thy1.2 antibody and complement according
to a published protocol from our laboratory [15]. In
brief, BM cells were flushed out from femur, tibia,
and humerus; strained through a 70-mm cell strainer
(BD, Franklin Lakes, NJ); and then resuspended in
Cytotoxicity Medium (Cedarlane, Hornby, Canada)
at a concentration of 1 107/mL. Anti-Thy1.2 mono-
clonal antibody (0.1 mg per 1 107 cells, clone 30H12;
BD Pharmingen, San Diego, CA) was added and
mixed. After a 60-minute incubation at 4C, the cells
were washed once and then resuspended in Cytotoxic-
ity Medium (Cedarlane) containing 1:10 Low-Tox-M
Rabbit Complement (Cedarlane). The cells were incu-
bated at 37C for 60 minutes and washed twice before
use. For the BM from Rag-12/2 mice, whole BM was
used directly without further T cell depletion.T Cell Separation
Purified CD41 T cells were separated from sple-
nocytes using antibodies against CD11b, CD45R,
DX5, Ter-119, and CD8 (Miltenyi Biotec, Cologne,
Germany) through negative selection. Effector mem-
ory phenotype TEa cells were obtained after depletion
of CD62L1 cells using anti-CD62L microbeads (Mil-
tenyi Biotec) from purified CD41 T cells. The purity
of the cell population was verified by flow cytometry
after magnetic separation. The cell doses used in the
experiments were adjusted based on T cell content.
Skin Transplantation
This procedure was based on a protocol published
by Markees et al. [16]. In brief, tail skin was removed
from sacrificed donors and cut into 0.5  0.5 cm2
pieces. The dorsal surface of anesthetized recipient
mice was shaved, washed with iodine solution, and
rinsed with an alcohol swab. A graft bed was prepared
with fine scissors by removing an area of epidermis
and dermis down to the level of the intrinsic muscle.
A graft was fitted to the prepared bed, sutured with
6-0 surgical sutures, and then covered with an adhesive
plastic bandage. After 4 days, the bandage was re-
moved. Skin graft survival was assessed each day by vi-
sual and tactile examination. Rejection was defined as
the first day at which the entire epidermal surface of
the graft was\10%.
Flow Cytometry Analysis
Blood (50 mL) or 1  106 mononuclear cells were
incubated with titrated antibodies for 15 minutes at
room temperature in the dark. RBCs were lysed with
FACS lysing solution (BD Biosciences, San Jose,
CA). Cells were stained with antibody cocktail and
then analyzed using a FASCanto flow cytometer equip-
ped with FACSDiva software (BD Biosciences). Abso-
lute cells counts were determined using a Flow-Count
Fluorospheres (BeckmanCoulter, Brea,CA).The anti-
bodies included FITC-conjugated anti-CD62L (clone
MEL-14), R-PE–conjugated anti-CD45.1 (clone
A20), cy-chrome-conjugated anti-CD44 (clone IM7),
and their isotype controls (all from BD PharMingen);
and FITC-conjugated anti–H-2Db (clone CTDb),
PE-conjugated anti-CD4 (clone CT-CD4), B220
(clone RA3-6B2), PE-Texas red–conjugated anti-
CD4 (clone RM4-5), tricolor-conjugated anti-CD4
(clone CT-CD4), CD8a (clone CT-CD8a), and their
isotype controls (Invitrogen, Carlsbad, CA).
Generation of Allospecific TEM
A total of 1  107 na€ıve TEa cells were transferred
intoRag-12/2mice.On the next day, 5 107 irradiated
(20Gy) host-type splenocytes were administered to re-
cipients through i.p. injection.More than 8weeks later,
some of the animals underwent transplantation with
1490 Biol Blood Marrow Transplant 18:1488-1499, 2012P. Zhang et al.allospecific antigen original skin grafts to observe
second-set rejection. Other animals were used to iso-
late TEM by depleting CD62L
1 cells using magnetic
beads. Many of the cells that were transferred into the
Rag-12/2 mice but were not challenged with alloanti-
gens also obtained a memory phenotype; these cells
were termed ‘‘TEM-like’’ and included as a control.
Analysis of Serum Cytokines
Serum was analyzed for 23 cytokines and chemo-
kines using the Protein Multiplex Immunoassay
Kit (Invitrogen) as described previously [17,18]. In
brief, Biosource Multiplex beads were vortexed
and sonicated for 30 seconds, after which 25 mL
was added to each well and washed twice with wash
buffer. The samples were diluted 1:2 with assay
diluent and loaded onto aMultiscreen BV 96-well filter
plate (Millipore, Billerica, MA) into which 50 mL of in-
cubation buffer had been added to each well. Serial di-
lutions of cytokine standards were prepared in parallel
and added to the plate. Samples were incubated on
a plate shaker at 600 rpm in the dark at room tempera-
ture for 2 hours. The assay plate was applied to a Milli-
pore Multiscreen Vacuum Manifold and washed twice
with 200 mL of wash buffer. Then 100 mL of biotiny-
latedAnti-MouseMulti-CytokineReporter (Millipore)
was added to each well. The plate was incubated on
a plate shaker at 600 rpm in the dark at room tempera-
ture for 1 hour, then applied to aMilliporeMultiscreen
Vacuum Manifold and washed twice with 200 mL of
wash buffer. Streptavidin-PE was diluted 1:10 in wash
buffer, and 100 mL was added directly to each well.
The plate was incubated on a plate shaker at 600 rpm
in the dark at room temperature for 30 minutes,
then applied to the vacuummanifold andwashed twice,
after which each well was resuspended in 100 mL of
wash buffer and shaken for 1 minute. The plate was
transferred to a Bio-Plex protein array reader
(Bio-Rad, Hercules, CA) for analysis. Cytokine con-
centrations were calculated using Bio-Plex Manager
3.0 software (Bio-Rad), with a 5-parameter curve-
fitting algorithm applied for standard curve calcula-
tions. Specifically, serum was assayed for IL-1a,
IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10,
IL-12(p40), IL-12(p70), IL-13, IL-17, eotaxin,
granulocyte-colony stimulating factor (G-CSF),
granulocyte macrophage-colony stimulating factor
(GM-CSF), TNF-a, kerotinocyte chemoattractant,
monocyte chemoattractant protein (MCP)-1, macro-
phage inflammatory protein (MIP)-1a and MIP-1b,
regulated upon activation normal T cell–expressed
and secreted (RANTES), and IFN-g.
Proliferation Assay
The proliferation assay was performed as de-
scribed previously [5]. Graded numbers of purifiedT cells (0.0156-2.5  105) were plated in 96-well,
flat-bottomed culture plates with 5  105 irradiated
(20 Gy) allogeneic splenocytes in a final volume of
200 mL. After incubation at 37C in 5%CO2 for a spec-
ified period (96 hours, except where indicated), cul-
tures were pulsed with 3H-thymidine (1 mCi [0.037
MBq]/well). After another 16 hours of incubation,
the cultureswere harvested and counted in aMicroBeta
Trilux liquid scintillation counter (EG&G Wallac,
Turku, Finland). Triplicate cultures were set up for
each cell population tested.
Carboxyfluorescein Diacetate Succinimidyl
Ester Assay
Carboxyfluorescein diacetate succinimidyl ester
(CFSE) staining was based on a protocol of Lyons
and Parish [19]. In brief, mononuclear cells were resus-
pended in PBS plus 0.1% FBS, after which a 10-mM
stock solution of 5- and 6-CFSE in DMSO was added
to a final concentration of 5 mM. The mixture was in-
cubated at 37C for 5 minutes, then immediately
washed 3 times in cold RPMI-1640 plus 10% FBS
cell culture medium. After the last washing, samples
were analyzed by flow cytometry.
GVHD Model
Lethally irradiated (10.5 Gy) mice were injected
i.v. through the tail vein with 1  107 T cell–depleted
(TCD) BM cells and purifiedT cells. Survival and clin-
ical evidence of GVHD, such as weight change, skin
changes (hair loss and erythema), diarrhea, and
hunched posture, were monitored for daily. Moribund
mice were killed humanely in accordance with an ani-
mal protocol approved by the DukeUniversity Institu-
tional Animal Care and Use Committee. Except where
indicated, the experiments were performed in the
TEa/CB6F1 system.
Statistical Analysis
Data are represented as mean 6 SD or mean 1
SD. Kaplan-Meier survival curves were created using
JMP software (SAS Institute, Cary, NC). Statistical
differences in animal survival were analyzed using
the log-rank test. Differences in CPM in the mixed
lymphocyte reaction (MLR) system and recipient
body weight changes were analyzed using the
2-tailed Student t test. For all tests, P \ .05 was
considered significant.RESULTS
Novel GVHD Model Induced by CD41 TCR
Transgenic T Cells Alone
In previously published studies [12,13], a
heterogeneous population of memory T cells
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only a small portion of total cells) was used to study
the effects of allospecific memory T cells on
GVHD. To investigate the role of allospecific
memory T cells in GVHD in more detail, we used
a GVHD model induced solely by TEa cells
described previously by Gonzalez et al. [20]. In that
study, the recipient CB6F1 mice were irradiated
with a sublethal dose (6.5 Gy), and approximately
60% of the recipients developed lethal GVHD de-
spite a large dose of TEa cells (4  106). We antici-
pated that we would not be able to generate such
high numbers of memory TEa cells. To develop our
model, we increased the irradiation dose to CB6F1
mice from a sublethal dose (6.5 Gy) to a lethal dose
(10.5 Gy). After irradiation, graded numbers
(1  103 to 1  105) of purified TEa cells from na€ıve
TEa mice were transplanted into CB6F1 recipients
together with 1  107 C57BL/6 TCD BM cells. As
few as 5  104 purified TEa cells were able to induce
lethal GVHD, resulting in the death of all recipients
within 20 days (Figure 1). Despite significant weight
loss observed in the recipients of 5  103 and
1 104 purified TEa cells, the majority of these recip-
ients survived more than 100 days posttransplanta-
tion. None of the recipients of 1  103 purified TEa
cells developed GVHD, and all of them survived
more than 100 days posttransplantation. Because
only 5  104 purified TEa cells are required to induce
lethal GVHD, this would be an ideal model for study-
ing the role of allospecific TEM in GVHD.
Generation of Allospecific TEM
Using the novel model of GVHD induced by TEa
cells, we next studied the ability of allospecific TEM to
induce GVHD. To obtain sufficient purified allospe-
cific TEM for testing, we used the T cell– and B cell–
deficient Rag-12/2 mouse model, which has been
used successfully in previous investigations to generate
memory T cells [21]. We first injected spleen cells
from na€ıve TEa mice containing 1  107 TEa cells
into Rag-12/2mice i.v. (Figure 2A). Then 18-24 hours
later, these mice were immunized with 5 107 CB6F1
irradiated (20 Gy) spleen cells through i.p. injection.
TEM cells were harvested from these mice at least 8
weeks after priming. Many of the T cells that were
transferred into the Rag-12/2mice but not challenged
with alloantigen also attained the memory phenotype
through homeostatic proliferation [4]. These TEM-
like cells were included as controls. At least 8 weeks af-
ter adoptive transfer and priming, we detected 0.3%-
27.7% TEa cells in peripheral blood and 4.2%-41%
TEa cells in spleen (Figure 2B). As shown in both pe-
ripheral blood and spleen,.90% of TEa cells became
TEM, and only 1% of TEa cells were TCM in TEM
donors. Similar results were obtained in TEM-like
cell donors.To ensure that functional memory T cells were
generated in the TEM donors, we transplanted
CB6F1 skin grafts into these mice. TEM donors re-
jected skin grafts faster than na€ıve TEa mice
(P \ .01), indicating that TEM donors are able to
mediate memory responses (Figure 2C). Because the
vast majority of memory phenotype T cells in allospe-
cific TEM donors were TEM, most likely the accelerat-
ing rejection of skin graft was mediated by TEM,
suggesting that TEM generated in this model are truly
functional memory T cells. Even though TEM-like cell
donors also contained mostly memory phenotype TEa
cells, they did not reject CB6F1 skin faster than na€ıve
TEa mice, suggesting that TEM-like cells might not
be fully functional. Although more analysis is needed
to confirm the functional differences between these
cells, our data indicate that both TEM-like cells and
TEM are unequivocally functional.
Purification and Characterization of Allospecific
TEM
To study the effect of allospecific TEM, we first
sorted purified na€ıve and effector memory phenotype
TEa cells by magnetic bead selection. Na€ıve TEa cells
were purified after depletion of all non-CD41 cells
from na€ıve TEa spleen cells. Both TEM-like cells and
TEM were purified after depletion of all non-CD4
1
cells, followed by deletion of all CD62L1 cells. The
purity of na€ıve TEa cells (CD62L1CD44low) was
94%. Contamination of na€ıve (CD62L1CD44low)
and TCM (CD62L
1CD44high) in both TEM-like cells
and TEM was only 1% (Figure 3A). To further ensure
that these cells were true memory T cells, we stained
them with additional memory T cell markers. Both
TEM-like cells and TEM exhibited a typical memory
T cell phenotype (Figure 3B).
This approach has been used by many previous
groups [21]. Moreover, we demonstrated in our model
that primed TEM donors mediated memory T cell re-
sponses (Figure 2C), and that purified allospecific TEM
from these mice bore a typical memory T cell pheno-
type (Figure 3B). Despite this strong evidence, we
wished to further ensure that the TEM generated using
this model are truly functional memory T cells by test-
ing them in an in vitro MLR assay. Primed TEM were
cultured with irradiated CB6F1 spleen cells, and the
proliferation potential was assessed over time. Com-
pared with both na€ıve TEa cells and TEM-like cells
controls, TEM mediated more rapid and stronger pro-
liferative responses on challenge with alloantigens
(Figure 3C). Taken together, these data indicate that
the allospecific TEM used in our studies were truly
functional memory T cells.
Allospecific Primed TEM Do Not Induce GVHD
We then tested the ability of primedTEM to induce
GVHD. Purified TEa cells (1  105/mouse) from
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Figure 1. A novel GVHD model induced by TEa CD41 TCR transgenic T cells alone. Graded numbers (1  103 to 1  105) of purified TEa cells
were transplanted into lethally irradiated CB6F1 recipients along with 1  107 TCD BM cells. Mice were monitored for the development of
GVHD. Each groups contained 4-5 mice. Consistent results were obtained using 1  104 and 1  105 TEa cells in more than 3 other independent
experiments. (A) Survival. P\.005 (5  104 or 1  105 versus TCD BM only, 1  103, 5  103, and 1  104). (B) Body weight. P\.001, 1  105
versus TCD BM only, 1  103, 5  103, and 1  104 on day 7 and 14; P\.05, 1  105 versus TCD BM only, 1  103, and 5  103 on day 21.
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ated CB6F1 mice along with 1  107 TCD BM cells.
All na€ıve TEa cell recipients developed GVHD soon
after transplantation, and all died within 1 week post-
transplantation (Figure 4). In contrast, none ofTEM re-
cipients developed GVHD, and all of them survived
more than 100 days posttransplantation. Similarly, nei-
ther clinical nor histological GVHD was observed in
TEM-like cell recipients. Although the difference was
not statistically significant, body weight did trend
lower in TEM-like cell recipients compared with
TCD BM-only recipients, suggesting that mild
GVHD might have developed in TEM-like cell recipi-
ents.Nevertheless, all TEM-like cell recipients survived
more than 100 days after transplantation. Based on the
data presented inFigures 1 and4, both allospecificTEM
andTEM-like cells are at least 20 times less potent in in-
ducingGVHD.These data clearly demonstrate that al-
lospecificTEM fromboth primed and unprimed donors
have a dramatically decreased ability to induceGVHD.
T Cell Expansion and Cytokine Secretion in
Allospecific Primed TEM Recipients
To investigate why primed TEM did not induce
GVHD, we monitored T cell expansion in primed
TEM recipents posttransplantation. To track TEa cells
in vivoduringGVHD,weused the samemodel as shown
in Figure 4, except with BM from Rag-12/2mice rather
than wild-type C57BL/6 mice. Because CD229.1 is
expressed only in the recipient CB6F1 cells and Rag-
12/2 mice were used as BM donors, TEa cells
(CD229.12CD41Va21) couldbemonitoredbyflowcy-
tometry (Figure 5A). The mice were sacrificed at days
11,13,15, and17 posttransplantation, and TEa cells
werequantified in peripheral blood.Unfortunately,TEa
cells were not detected in any animals at any time points
before day 17. On day 17, levels of blood and spleenTEa cells were significantly lower in both TEM and
TEM-like cell recipients than in na€ıveTEa cell recipients
(P \ .05; Figure 5B). Similar results were obtained
in liver and BM (data not shown). These data indicate
significantly inhibited T cell expansion in both TEM-
like cell and TEM recipients during GVHD, at least at
the peak of na€ıve T cell expansion. Because allospecific
TEM are able to proliferate and expand in response to al-
loantigen, as shown in the MLR assay (Figure 3C), our
in vivo T cell expansion data suggest that, similar to
memory T cells from unprimed donors [22,23],
allospecific TEM also mediates an abortive alloresponse
after hematopoietic stem cell transplantation.
Cytokine storm is a downstream cascade occurring
after T cell activation and clonal expansion during
GVHD [24]. Multiple inflammatory cytokines are in-
volved in the pathogenesis of GVHD. To investigate
whether an abortive T cell response mediated by allo-
specific primed TEM leads to a disruption in inflamma-
tory cytokine production after transplantation, we
measured cytokine changes in allospecifc TEM recipi-
ents. Plasma was harvested at days 13, 15, 17, and
110, and levels of various cytokines and chemokines
were measured by multiplex bead-based assays. As
shown in Figure 5C, multiple cytokines in Th1 (IL-2,
IL-3, IL-12P40, IFN-g, TNF-a), Th2 (IL-4, IL-5,
IL-10), Th17 (IL-1a, IL-1b, IL-6, IL-17), hematopoi-
etic families (G-CSF and GM-CSF), and chemokines
(MIP-1a, MIP-1b, RANTES, MCP-1, kerotinocyte
chemoattractant, and eotaxin) were increased in na€ıve
TEa cell recipients comparedwithTCDBM-only con-
trols starting at day 15 (P\ .05). This trend lasted
at least until day 110. In contrast, none of these cyto-
kines were increased in both TEM-like cell and TEM re-
cipients. These data demonstrate that cytokine storm is
attenuated in allospecific TEM cells recipients after
hematopoietic stem cell transplantation.
Figure 2. Generation of allospecificTEM. To generate allospecficTEM, TEa spleen cells containing 1 107 TEa T cells were first transferred into Rag-12/2
mice. These mice were subsequently immunized with irradiated CB6F1 splenocytes 18-24 hours later. (A) A schema showing how effector memory TEa
cellswere generated. The details of howallospecificTEMwereobtained are describedMaterials andMethods. (B) Phenotypes of TEa cells TEM donormice.
Flow cytometry analysis was performed in TEM donor mice at least 8 weeks after priming. (C) TEM donor mice mediated second-set skin graft rejection.
At least 8 weeks after priming, TEM donor mice were transplanted with CB6F1 skin grafts. Graft survival was observed daily. P \ .01, TEM
donors versus other groups. P 5 .057, TEM-like donors versus na€ıve TEa mice.
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Figure 3. Purification and characterization of allospecific TEM. At least 8 weeks after priming, spleen cells were first harvested from Rag-1
2/2mice that
contained TEa cells. CD41 cells were then negatively selected using magnetic beads. Purified effector memory TEa cells were finally isolated after de-
pletion of CD62L1 cells using magnetic beads. A representative of at least two similar experiments is shown. (A) Phenotypes of purified TEa cells used
for the subsequent experiments. (B) Additional memory T cell markers. (C) MLR. Purified TEa cells (62,500 cells/well) from different groups were
cultured with 5  105 irradiated CB6F1 spleen cells. Proliferation was determined by 3H-thymidine incorporation. *P \ .05, TEM versus
others; #P \ .05, TEM-like versus na€ıve;
&P \ .05, na€ıve versus others.
1494 Biol Blood Marrow Transplant 18:1488-1499, 2012P. Zhang et al.Allospecific TEM Undergo Apoptosis and Die
Faster Than Na€ıve T Cells
Previously published data from our group suggest
that inability of memoryT cells from unprimed donors
to induce GVHD is a result of an abortive alloresponse
[22]. Our data (Figures 3C and 4) suggest that this may
be the case for allospecifc TEM as well. To understand
why allospecific TEM are able to respond to alloantigen
initially but fail to sustain the response, we studied pro-
liferation and cell apoptosis/death of allospecific TEM
simultaneously. T cells were first labeled with CFSE
and then cultured with irradiated CB6F1 cellsin vitro. After 72 hours in culture, cells were harvested,
and the percentages of apoptotic and dead cells in each
cell generation were determined by flow cytometry.
The results indicate that compared with na€ıve TEa
cells, more TEM-like cells and TEM underwent apo-
ptosis in all generations during alloresponses
(Figure 6).
Allospecific TEM Are Deleted in GVHD
Recipients but Not in Skin Graft Recipients
The data presented here demonstrate that despite
the ability of allospecific TEM to respond to
Figure 4. Allospecific TEM do not induce GVHD. Purified TEa cells (1  105) from each group were transplanted into lethally irradiated CB6F1 recip-
ients along with 1  107 TCD BM cells. The data were pooled from 3 independent experiments with similar results. Mice were then monitored for the
development of GVHD. Survival was monitored daily. (A) Survival. P\ .0001, na€ıve versus other groups. (B) Body weight. P\ .001, TEM versus
na€ıve at days 17, 114, and 121.
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induce GVHD after allogeneic stem cell transplanta-
tion (Figure 4). Our findings suggest that allospecific
primed TEM were nonresponsive to alloantigen in
so-called ‘‘GVHD recipients.’’ To test this, we isolated
spleen cells from allospecific TEM recipients and re-
challenged them with irradiated CB6F1 spleen cells
in vitro. Because all of the na€ıve TEa cell recipients
died of GVHD early after transplantation and were
not available to serve as positive controls, we included
TEa-containing Rag-12/2mice that had previously re-
jected CB6F1 skin grafts as a positive control (termed
‘‘skin graft recipients’’). Spleen cells from TEM recipi-
ents did not demonstrate a response on challenge with
alloantigen, whereas those from skin graft recipients
responded vigorously against alloantigen, as expected
(Figure 7A). These data demonstrate that allospecific
TEM become tolerant to alloantigen on transfer to ir-
radiated allogeneic recipients.
Clonal deletion is one of the central mechanisms
responsible for tolerance induction [25]. To determine
whether this mechanism is responsible for tolerance
observed in allospecific TEM recipients, we measured
the numbers of allospecific cells (TEa) in long-term al-
lospecific TEM recipients. The same experimental
model as described in Figure 5 was used in this exper-
iment, allowing us to trackTEa cells by flow cytometry
in vivo. Virtually no TEa cells (\1 cell/mL blood) were
detected in TEM GVHD recipients (Figure 7B),
whereas TEa cells were readily detectable in skin graft
recipients. These data demonstrate that allospecific
TEM were clonally deleted in GVHD recipients.
Clonal deletion of allospecific TEa cells might have
occurred very early, given the very low number of
TEa cells detected in blood on day 17 (Figure 5B).DISCUSSION
Several different groups have independently dem-
onstrated that TEM from unprimed donors have dra-matically decreased the ability to induce GVHD
[5-9]. Although prevention of GVHD by selection of
TEM holds great translational potential, concerns
remain. One of the major concerns is that, unlike
memory T cells from experimental animals housed at
clean facilities, human memory T cells contain cells
that can cross-react with alloantigens [4]. In some hu-
man donors, allospecific na€ıve T cells may acquire
a memory phenotype after homeostatic proliferation
or after exposure to alloantigens in the form of blood
transfusion, previous transplantation, or pregnancy
[4]. Both cross-reactive and allospecific memory T cells
may induce GVHD.
To address this concern, we studied the effects of
allospecific TEM on GVHD using a novel GVHD
model induced solely by TCR transgenic T cells. Be-
cause antigen-specific TCR transgenic T cells can be
easily tracked in vivo, we also anticipated that studies
using this model would also provide insight into the
mechanism responsible for the decreased ability of
TEM to induce GVHD. Our present findings demon-
strate that allospecific TEM are unable to induce
GVHD (Figure 4). Given previous reports suggesting
that alloreactive TEM have decreased ability to induce
acute GVHD [12,13], these results are not completely
surprising. However, our data conflict with the current
dogma that memory T cells mediate stronger and
more effective immune responses [1].
Given our use of a T cell transgenic model to gen-
erate allospecific TEM in the present study, an immedi-
ate concern is whether the allospecific TEM used in our
experiments are true memory T cells. Although our
model has been used by numerous previous groups to
generate memoryT cells [21], whethermemoryT cells
generated in this system differ from those generated in
a physiological condition (ie, T cell–replete host) re-
mains unclear and of concern. We took several mea-
sures to ensure that the cells used in this study were
true memory T cells. First, because longevity is a hall-
mark of memory cells, we waited at least 8 weeks after
Figure 5. T cell expansion and cytokine secretion in allospecific TEM recipients. Purified TEa cells (1  105/mouse) from each group were trans-
planted into lethally irradiated CB6F1 recipients along with 1  107 TCD BM cells. Numbers of TEa cells were measured at day 17 by using
flow cytometry. Cytokines were measured at day 13, 15, 17, and 110 by using multiplex bead-based assays. (A) Representative histograms
showing how TEa cells were measured in transplantation recipients using flow cytometry. (B) T cell expansion in vivo. Similar results were ob-
tained in liver and BM. *P \ .05, na€ıve versus TEM. (C) Cytokine changes in plasma. P \ .05, na€ıve versus TEM in all cytokines; P \ .05, in IL-
12P40, TNF-a, RANTE. *P\ .05, TCD BM only versus na€ıve; #P\ .05, na€ıve versus TEM; P 5 NS, TEM versus TCD BM only except GM-CSF,
IFN-g, MIP-1b on day 15, IL-17 on day 17, IL-2, IL-3, IL-5, GM-CSF, and MCP-1 on day 110; P 5 NS, TEM-like versus TCD BM only except
RANTE on day 17, IL-3, IL-5, eotaxin, and MCP-1 on day 110.
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Figure 6. Allospecific TEM undergo apoptosis and die faster than na€ıve T cells do in vitro. Purified TEa cells from different groups were labeled with
CFSE. Labeled TEa cells (1.25 105/well) were cultured with irradiated CB6F1 spleen cells (5 105/well) for 3 days. At the end of the culture, cells were
stained with Anexin V and 7- AAD. The dot plots were gated on 7-AAD2 (top panel) or total (bottom panel) CD229.12CD41Va21 (TEa) cells. The
values represent percent apoptotic (anexinV17-AAD2) or dead cells (7-AAD2) among TEa cells. A representative of three similar experiments with
similar results is shown.
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contamination of effector cells. Second, we verified
that the donors, in whom the vast majority of memory
T cells bore an effector memory phenotype
(Figure 2B), were able to mediate second-set skin
rejection (Figure 2C), indicating that they had func-
tional memory T cells. Third, we used cells bearing
a typical TEM phenotype, such as high expression of
CD44 and low expression of CD62L (Figures 2B and
3A and B). Finally, we used TEM that mediated
a faster and stronger proliferative response against
alloantigen (Figure 3C). Taken together, our findingsFigure 7. Allospecific TEM are deleted in GVHD but not skin graft recipien
cipients (Figure 4) were harvested 84 days after transplantation. Proliferative
eral blood were determined. (A) Proliferation against alloantigens. Various nu
(5  105/well) for 3 days. Proliferation was determined by 3H-thymidine inc
All experiments were repeated at least twice and yielded similar results. *P\
determined by flow cytometer. Each group contained at least 5 animals. *Pverify that the cells used were fully functional memory
T cells, and these allospecific memory T cells are un-
able to induce GVHD.
Why are these functional allospecific TEM unable
to induce GVHD? Clonal expansion of allospecific T
cells is essential for the induction of GVHD [24]. In
our model, clonal expansion of allospecific TEa cells
can be easily tracked by flow cytometry in vivo
(Figure 5A). Our data demonstrate that allospecific
TEM recipients have significantly lower numbers of
TEa cells compared with na€ıve TEa recipients at day
17, demonstrating that allospecific TEM do notts. Spleen cells from skin graft recipients (Figure 2C) and GVHD re-
responses against alloantigen and the numbers of TEa cells in periph-
mbers of spleen cells were cultured with irradiated CB6F1 spleen cells
orporation. Results are represented as mean 6 SD of triplicate wells.
.05. (B) Peripheral TEa cell counts. Absolute counts of TEa cells were
\ .01.
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a result, the ‘‘cytokine storm,’’ a critical step in the
GVHD cascade [24], might be attenuated in allospe-
cific TEM recipients (Figure 5C). Inability of allospe-
cific TEM to proliferate and fully expand and the
subsequent failure to produce inflammatory cytokines
may explain why both TEM-like cells and TEM could
not induce GVHD. Long-term follow-up of TEa cells
revealed that allospecific TEa cells are clonally deleted
in allospecific TEM recipients (Figure 7B), further con-
firming why allospecific TEM recipents become toler-
ant to alloantigen, never develop GVHD, and
survive long-term after allogeneic hematopoietic
stem cell transplantation.
Despite the abundant evidence of the weak im-
mune responses of allospecific TEM during GVHD
(Figures 4, 5, and 7), why allospecific TEM do not
respond well in GVHD is not clear. One hypothesis
based on our previously published data using
memory T cells from unprimed donors [22] is that al-
loresponses mediated by TEM cannot be sustained to
induce GVHD (the ‘‘abortive response’’ hypothesis).
The MLR data presented in Figure 3C are consistent
with this hypothesis. Simultaneously detected cell pro-
liferation and apoptotic and necrotic death after activa-
tion (Figure 6) further demonstrate that allospecific
TEM are more prone to apoptosis after activation com-
pared with na€ıve T cells. The susceptibility of allospe-
cific TEM to apoptosis could be a result of T cell
exhaustion [26], given the high PD-1 expression seen
in these cells (Figure 3B).
Nonetheless, the abortive response hypothesis can-
not explainwhy allospecificTEMare able tomediate re-
call immune responses in the skin rejection setting
(Figure 2C) but are unable to mediate meaningful im-
mune responses in the GVHD setting. One of the ma-
jor differences in these 2 settings is that abundant
alloantigens persist long-term in the GVHD setting
but not in the graft rejection setting. Prolonged expo-
sure to antigens has been reported to induce clonal de-
letion or clonal anergy in GVHD [20,27] and other
settings [28,29]. In the GVHD setting, allospecific
TEM could have been deleted owing to the prolonged
exposure to alloantigen, leading to antigen-specific tol-
erance (Figure 7). In the graft rejection setting, alloan-
tigens do not exist after skin grafts are rejected by
allogeneic TEM. These allospecific TEM survive long-
term. This explanation is supported by the data pre-
sented in Figure 7B. In fact, allospecific na€ıve T cells
also have been reported to become anergic or deleted
after prolonged exposure to antigen [20,27,30,31].
Because TEM do not express homing molecule
CD62L, it was initially thought that the inability of
TEM to induce GVHD was due to their inability to
home to lymph node and Peyer patches (‘‘homing’’ hy-
pothesis).We were unable to test this hypothesis in the
current model because a very low T cell dose was used,and allospecific T cells could not be detected in all re-
cipients early after transplantation. However, previ-
ously published data from us and others suggest that
this is not the main explanation of why memory T cells
do not induce GVHD. In a previous study, we demon-
strated that TCM, which are able to home to secondary
lymphoid organs, do not induce GVHD [22]. More-
over, Anderson et al. [32] reported that enforced con-
stitutive expression of CD62L onTEM does not endow
these cells with the ability to causeGVHD.Third, sec-
ondary lymphoid organs are not required for na€ıve T
cells to induce GVHD [33]. These findings suggest
that the inability of allospecific TEM to induce
GVHD is not likely the result of a homing defect.
In summary, we have demonstrated that allospecifc
TEM are unable to induce GVHD using a novel
GVHD model induced by CD41 TCR transgenic T
cells. Allospecific TEM recipients become tolerant to
alloantigen as a result of clonal deletion. Even though
allospecific TEM are able to respond to alloantigen ini-
tially, the expansion of these cells and inflammatory
cytokine production duringGVHD is dramatically de-
creased. The inability of allospecificTEM to sustain the
alloresponse may be a result of enhanced activation-
induced cell death. These observations provide insight
into how allospecific TEM respond to alloantigen dur-
ing GVHD, and underscore the fundamental differ-
ences in alloresponses mediated by allospecific TEM
in graft rejection and GVHD settings.ACKNOWLEDGMENTS
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